U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07588932) titled 'Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors' on May 09.
Brief Summary: The goal of this trial is to study if the concomitant administration of Telmisartan, Cilostazol IR (immediate release), and Metformin ER (extended release) can help stroke survivors make greater gains in movement and recovery during robot-assisted arm and hand rehabilitation.
Study Start Date: May 18
Study Type: INTERVENTIONAL
Condition:
Stroke
Intervention:
DRUG: Telmisartan, Metformin, Cilostazol
Participants will be instructed to take the low dose of the proposed pharmacotherapy (i.e., Telmisartan 20mg QD, Metformin ER 5...